Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000528878 | SCV000654117 | benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 | 2024-12-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001558105 | SCV001779981 | likely benign | not provided | 2019-10-25 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001558105 | SCV005214292 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003962586 | SCV004784199 | likely benign | B4GAT1-related disorder | 2019-08-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |